New York Oncology Hematology - Albany Cancer Center /ID# 269345 — Albany, New York

New York Oncology Hematology - Albany Cancer Center /ID# 269345 is a clinical research site located in Albany, New York, United States 12206-5013.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

New York Oncology Hematology - Albany Cancer Center /ID# 269345 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology - Albany Cancer Center /ID# 269345?

New York Oncology Hematology - Albany Cancer Center /ID# 269345 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology - Albany Cancer Center /ID# 269345 conducted?

New York Oncology Hematology - Albany Cancer Center /ID# 269345 has 1 clinical trials on record, with 1 currently active. Their work covers Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive.

Is New York Oncology Hematology - Albany Cancer Center /ID# 269345 accredited by Crixeo Health?

New York Oncology Hematology - Albany Cancer Center /ID# 269345 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Oncology Hematology - Albany Cancer Center /ID# 269345?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.